NCT03515252View on ClinicalTrials.gov

Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 26, 2005

Primary Completion Date

November 2, 2006

Study Completion Date

June 7, 2007

Conditions
NSCLC Stage IIIBNSCLC Stage IVHepatocellular Carcinoma by BCLC StageLung CancerLiver Cancer
Interventions
BIOLOGICAL

Immune Killer Cells (IKC)

Sponsors
All Listed Sponsors
lead

Ivy Life Sciences, Co., Ltd

INDUSTRY

NCT03515252 - Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer | Biotech Hunter | Biotech Hunter